Alternative Treatment Option for Multiple Myeloma

According to recent research presented at ASCO, adding which targeting agent to standard of care carfilzomib, lenalidomide, and dexamethasone is a safe and efficacious alternative to ASCT for patients with multiple myeloma?

-----

A. Daratumumab

B. Elotuzumab 

C. Pembrolizumab

D. Nivolumab

-----

See the answer here.